Your session is about to expire
← Back to Search
Leg Length Discrepancy Techniques for Leg Length Discrepancy
N/A
Recruiting
Led By Emily R Dodwell, MD MPH FRCSC
Research Sponsored by Hospital for Special Surgery, New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Must not have
Patients undergoing additional orthopedic procedures at time of epiphysiodesis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years (end of study)
Awards & highlights
Study Summary
This trial is testing two different methods for correcting leg length discrepancy, to see which one is more successful. The primary outcome is failed epiphysiodesis, which is defined as one or more of the following: development of angular deformity > 5°, revision epiphysiodesis, or growth inhibition < 70% of expected.
Eligible Conditions
- Leg Length Discrepancy
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
You are having other orthopedic procedures done at the same time as the epiphysiodesis procedure.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 years (end of study)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years (end of study)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Failure of Epiphysiodesis
Secondary outcome measures
Change in Physeal Growth
Complications
Days Until Return to Sports
+10 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Percutaneous Screw EpiphysiodesisExperimental Treatment2 Interventions
In the distal femur, guide wires will be placed in an antegrade fashion, with an 8 mm skin incision proximal to the physis both medially and laterally. The guide wire will be placed with the medial wire crossing the physis at the junction of the middle and medial third of the physis. The lateral guide wire will cross the physis at the junction of the lateral and middle third of the physis. The wires will extend into the epiphysis, but will not enter the joint. The guide wires will be over drilled with a 5 mm drill, and 7.3 mm fully threaded cannulated screws will be placed across the growth plate. For tibias, screw placement will be retrograde, with 8 mm incisions made medially and laterally distal to the physis, with guide wires aiming proximally.
Group II: Percutaneous Drill EpiphysiodesisActive Control2 Interventions
A 5 mm incision will be made centered over the physis both medially and laterally. A 4.5 mm drill will be passed repeatedly across the physis in a divergent manner. Curettes will then be used to further remove and disrupt the growth plate. Fluoroscopy will be used throughout to ensure proper passage of the drill and curettes. Omnipaque dye will then be inserted to confirm ablation of the physis.
Find a Location
Logistics
Travel, including flights, are covered
Your expenses for travel tickets for this trial will be reimbursed.
Who is running the clinical trial?
Hospital for Special Surgery, New YorkLead Sponsor
242 Previous Clinical Trials
59,164 Total Patients Enrolled
Boston Children's HospitalOTHER
759 Previous Clinical Trials
5,579,390 Total Patients Enrolled
The Hospital for Sick ChildrenOTHER
684 Previous Clinical Trials
6,944,826 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a bone condition that can cause unpredictable bone growth.You are expected to grow for at least one more year.You are still growing and your bones have not fully developed.You are pregnant.You are still growing and your bones have not fully developed yet.You have to have at least one more year of growth left.You are having other orthopedic procedures done at the same time as the epiphysiodesis procedure.You are still growing and need surgery to stop the growth of your lower leg bone(s).The length of your legs is expected to be different by 2-7 cm.One leg is expected to be shorter by 2 to 7 centimeters.
Research Study Groups:
This trial has the following groups:- Group 1: Percutaneous Screw Epiphysiodesis
- Group 2: Percutaneous Drill Epiphysiodesis
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger